Clinical Trial Update: Renoprotective Effects of Dapagliflozin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating renoprotective effects of dapagliflozin in type 2 diabetes; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathies
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: M.H.H. Kramer | Conditions: Diabetes Mellitus, Type 2, Diabetic Nephropathies | Phase 4 | Status: COMPLETED | Results posted: 2020-07-07